Frontlight ResearchEarly access
What researchers published on Lung cancer
162,321 papers, newest first.
Showing 20 of 5,530
Randomised trialDirozalkib versus Crizotinib in Advanced Anaplastic Lymphoma Kinase Inhibitor-Naïve ALK-Positive Non-Small-Cell Lung Cancer: A Multicenter, Randomized Phase III Trial.Cancer communications (London, England)
Trial resultCombined Immunotherapy and Hybrid Dose-Fraction Radiotherapy for Driver-Negative Metastatic NSCLC: A Phase II Trial with Parallel Preclinical Studies.Cancer communications (London, England)
Randomised trialEffects of CT-guided Radiofrequency Versus Microwave Ablation on Pulmonary Function in Individuals with Pulmonary Tumors: A Prospective Multicenter Randomized Trial.Radiology. Imaging cancer
In plain wordsRead moreRead the paper on PubMedRandomised trialTransbronchial Cryobiopsy for the Diagnosis of Peripheral Pulmonary Lesions: A Prospective Randomized Controlled Study.Journal of visualized experiments : JoVE
In plain wordsRead moreRead the paper on PubMedTrial resultA CCL21 gene-modified dendritic cell vaccine combined with pembrolizumab in advanced non-small cell lung cancer: a phase I trial.Nature communications
In plain wordsRead moreRead the paper on PubMedRandomised trialThalidomide dose selection for prevention of camrelizumab-induced reactive cutaneous capillary endothelial proliferation: a multicenter, randomized phase II trial.Frontiers in immunology
In plain wordsRead moreRead the paper on PubMedRandomised trialEarly functional deterioration during first-line ICI-based therapy in advanced NSCLC: implications for supportive care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
In plain wordsRead moreRead the paper on PubMedRandomised trialAutomated Opportunistic Bone Mineral Density Assessment at Low-Dose CT Lung Cancer Screening: Incident Vertebral Fractures and Mortality.Radiology
In plain wordsRead moreRead the paper on PubMedRandomised trialRuzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.Lancet (London, England)
Randomised trialClosed Versus Open Vent Port Techniques and the Disconnection Technique for Optimizing Lung Collapse With Bronchial Blockers in Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Trial.The clinical respiratory journal
In plain wordsRead moreRead the paper on PubMedTrial resultEffect of Acupuncture for Loss of Appetite in Advanced Lung Cancer Undergoing Immunotherapy: Protocol of a Randomized Controlled Trial.Integrative cancer therapies
Trial resultEffects of multiple low-dose intranasal dexmedetomidine administration on postoperative pulmonary complications in elderly patients undergoing thoracoscopic radical resection of lung cancer: a single-center randomized controlled trial.Frontiers in pharmacology
In plain wordsRead moreRead the paper on PubMedRandomised trialFirmonertinib in advanced non-small cell lung cancer with epidermal growth factor receptor P-loop and αC-helix compressing mutations.Cancer cell
Trial resultLazertinib plus pemetrexed and carboplatin in patients with EGFR-mutant advanced non-small cell lung cancer after progression on lazertinib.European journal of cancer (Oxford, England : 1990)
In plain wordsRead moreRead the paper on PubMedRandomised trialCamrelizumab plus chemotherapy as induction therapy followed by concurrent chemoradiotherapy and camrelizumab consolidation in limited-stage small cell lung cancer: a randomized phase II trial.Signal transduction and targeted therapy
In plain wordsRead moreRead the paper on PubMedTrial resultEfficacy and safety of induction benmelstobart plus anlotinib and chemotherapy followed by concurrent chemoradiotherapy and benmelstobart consolidation versus concurrent chemoradiotherapy followed by benmelstobart consolidation in patients with unresectable stage III NSCLC: a randomized, controlled, multicenter phase II trial protocol (BEAM-LUNG).Frontiers in immunology
Trial resultCanakinumab with chemoradiation and durvalumab consolidation in unresectable stage III non-small cell lung cancer: the phase I/II CHORUS trial.Nature communications
In plain wordsRead moreRead the paper on PubMedRandomised trialDexketoprofen Trometamol Plus Sufentanil for Analgesia After Thoracoscopic Radical Resection of Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial.Drug design, development and therapy
In plain wordsRead moreRead the paper on PubMedTrial resultFarletuzumab ecteribulin, a folate receptor alpha (FRα) antibody-drug conjugate, in select advanced cancers: An open-label, multicenter, phase 1/2 dose-finding study.Gynecologic oncology
In plain wordsRead moreRead the paper on PubMedTrial resultSUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy.Future oncology (London, England)